An autochthonous case of cutaneous bacillary angiomatosis not related to major immunosuppression: An emerging or overlooked disease?

Int J Infect Dis. 2024 Jan:138:21-24. doi: 10.1016/j.ijid.2023.11.016. Epub 2023 Nov 14.

Abstract

Cutaneous bacillary angiomatosis (cBA) is a vascular proliferative disorder due to Bartonella henselae or Bartonella quintana that has been mostly described in people living with HIV. Since cBA is considered to be rare in hosts not affected by major immunosuppression, it could be underdiagnosed in this population. Moreover, antimicrobial treatment of cBA has been poorly validated, thus reporting experiences on this clinical entity is important. We reported a challenging and well-characterized case of an Italian 67-year-old gentleman without a history of major immunocompromizing conditions, although he was affected by conditions that can be associated with impaired immune function. The patient reported herein was diagnosed after a long time since the initiation of symptoms and was successfully treated with combined antibiotic therapy including macrolides and quinolones under the guidance of molecular test results. Physicians should consider cBA as a possible manifestation of Bartonella spp. Infection in patients not suffering from major immunocompromizing conditions. Until evidence-based guidelines are available, molecular tests together with severity and extension of the disease can be useful to personalize the type of treatment and its duration.

Keywords: Bacillary angiomatosis; Bartonella; Emerging disease; PCR.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Angiomatosis, Bacillary* / complications
  • Angiomatosis, Bacillary* / diagnosis
  • Angiomatosis, Bacillary* / drug therapy
  • Anti-Bacterial Agents / therapeutic use
  • Bartonella henselae*
  • Bartonella quintana*
  • Humans
  • Immunosuppression Therapy
  • Male
  • Skin

Substances

  • Anti-Bacterial Agents